It appears that specific ways of inactivation of p16 in cancer of head and neck are related to specific patient risk profiles(p16INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas). This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.